Results 31 to 40 of about 333,932 (156)
AB0402 Rituximab may delay the movement of rheumatoid arthritis patients on cardiorenal continuum: results from a prospective observational single-centre cohort study [PDF]
Annals of the Rheumatic Diseases, 2017 Background Similarities in risk factors, initial stages, progression and final stage of both atherosclerotic cardiovascular disease (CVD) and chronic kidney disease (CKD) allowed formulating a concept of cardiorenal continuum. 1 CVD and CKD remain the main causes of mortality in rheumatoid arthritis (RA) patients.
IR Gaisin +6 more
openaire +1 more source
Cardiorenal Effects of Secretin_TableS2.pdf
, 2021 Supplemental Table 2: Cardiorenal Effects of ...
Sanna Laurila (11631379)
core +1 more source
Cardiorenal Effects of Secretin_FigS1.pdf
, 2021 Supplemental Figure S1: Cardiorenal Effects of ...
Sanna Laurila (11631379)
core +1 more source
Cardiorenal Effects of Secretin_TableS1.pdf
, 2021 Supplemental Table S1: Cardiorenal Effects of ...
Sanna Laurila (11631379)
core +1 more source
Cardiorenal Effects of Secretin_FigS2.pdf
, 2021 Supplemental Figure S2: Cardiorenal Effects of ...
Sanna Laurila (11631379)
core +1 more source
Cardiorenal syndrome and diabetes: an evil pairing [PDF]
, 2023 Cardiorenal syndrome; Diabetes mellitus; Heart failureSíndrome cardiorrenal; Diabetes mellitus; Insuficiencia cardiacaSíndrome cardiorenal; Diabetis mellitus; Insuficència cardíacaCardiorenal syndrome (CRS) is a pathology where the heart and kidney are ...
Toni Soriano Colome +11 more
core +1 more source
Practical Approaches to the Management of Cardiorenal Disease beyond Congestion [PDF]
Background: The coexistence of heart and kidney diseases, also called cardiorenal syndrome, is very common, leads to increased morbidity and mortality, and poses diagnostic and therapeutic difficulties.
Díez, Javier +12 more
core +1 more source
Cardiorenal syndrome: Mechanisms, risk and treatment
, 2010 Accelerated cardiovascular disease is a frequent complication of chronic kidney disease. Individuals with evidence of renal functional impairment are more likely to die of cardiovascular events than to progress to end stage renal disease.
Berbari A.E., Mancia G.
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Information on the safety profile of antidiabetic medications is essential for informed treatment decisions in type 2 diabetes mellitus. Although this information is available in regulatory documents of individual drugs, a comprehensive overview across all approved antidiabetics is lacking.
David Liang +5 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi +4 more
wiley +1 more source